Determinants of smoking cessation attempts among HIV-infected patients: Results from a hospital-based prospective cohort

Current HIV Research

Volumn 8, Issue 3, 2010, Pages 212-217

  Encrenaz, Gaelle ^a,b   Bénard, Antoine ^a,b,c   Rondeau, Virginie ^b,d   Bonnet, Fabrice ^c   Lazaro, Estibaliz ^c   Neau, Didier ^c   Dupon, Michel ^c   Dabis, François ^a,b,c   Mercié, Patrick ^c   Chêne, Geneviève ^a,b,c  

^a Centre of Clinical Investigation Clinical Epidemiology   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d INSERM   (France)

Author keywords

Cohort studies; Human immunodeficiency virus; Smoking cessation; Survival analysis

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE TRANSMISSION; DRUG ABUSE; DRUG INJECTION VOLUME; FEMALE; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; REINFORCEMENT; SMOKING; SMOKING CESSATION; HOSPITAL; MIDDLE AGED; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT;

ADULT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HOSPITALS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SMOKING CESSATION;

EID: 77954156237     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016210791111089     Document Type: Article

References (25)

1. Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998; 352: 1725-30.
2. Mocroft A, Ledergerber B, Katlama C, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003; 362: 22-9.
3. Survival after introduction of HAART in people with known duration of HIV-1 infection. The CASCADE Collaboration. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet 2000; 355: 1158-9.
4. Bonnet F, Morlat P, Chene G, et al. Causes of death among HIVinfected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999. HIV Med 2002; 3: 195-9.
5. Louie JK, Hsu LC, Osmond DH, et al. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998. J Infect Dis 2002; 186: 1023-7.
6. Jain MK, Skiest DJ, Cloud JW, et al. Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999-2000. Clin Infect Dis 2003; 36: 1030-8.
7. Lewden C, May T, Rosenthal E, et al. Causes of death among HIVInfected adults in France in 2005 and evolution since 2000. In: 14th Conference on Retroviruses and Opportunistic Infections. Los- Angeles 2007.
8. Bonnet F, Chene G, Thiebaut R, et al. Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000-2004. HIV Med 2007; 8: 547-54.
9. Benard A, Tessier JF, Rambeloarisoa J, et al. HIV infection and tobacco smoking behaviour: prospects for prevention? ANRS CO3 Aquitaine Cohort, 2002. Int J Tuberc Lung Dis 2006; 10: 378-83.
10. Friis-Moller N, Weber R, Reiss P, et al. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study. Aids 2003; 17: 1179-93.
11. Benard A, Bonnet F, Tessier JF, et al. Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort. AIDS Patient Care STDS 2007; 21: 458-68.
12. Duval X, Baron G, Garelik D, et al. Living with HIV, antiretroviral treatment experience and tobacco smoking: results from a multisite cross-sectional study. Antivir Ther 2008; 13: 389-97.
13. Grant BF, Hasin DS, Chou SP, et al. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2004; 61: 1107-15.
14. Thiebaut R, Morlat P, Jacqmin-Gadda H, et al. Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment. Groupe d'Epidemiologie du SIDA en Aquitaine (GECSA). Aids 2000; 14: 971-8.
15. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41: 1-19.
16. Rondeau V, Gonzalez JR. frailtypack: a computer program for the analysis of correlated failure time data using penalized likelihood estimation. Comput Methods Programs Biomed 2005; 80: 154-64.
17. van Loon AJ, Tijhuis M, Surtees PG, Ormel J. Determinants of smoking status: cross-sectional data on smoking initiation and cessation. Eur J Public Health 2005; 15: 256-61.
18. Osler M, Prescott E. Psychosocial, behavioural, and health determinants of successful smoking cessation: a longitudinal study of Danish adults. Tob Control 1998; 7: 262-7.
19. Kessler RC, Aguilar-Gaxiola S, Andrade L, et al. Mental-substance comorbidities in the ICPE surveys. Psychiatria Fennica 2001; 32: 62-80.
20. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 617-27.
21. Prochaska JO, Velicer WF, DiClemente CC, Fava J. Measuring processes of change: applications to the cessation of smoking. J Consult Clin Psychol 1988; 56: 520-8.
22. Reynolds NR. Cigarette smoking and HIV: more evidence for action. AIDS Educ Prev 2009; 21: 106-21.
23. Turner J, Page-Shafer K, Chin DP, et al. Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection. AIDS Patient Care STDS 2001; 15: 615-24.
24. Peretti-Watel P, Spire B, Lert F, Obadia Y. Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003). Drug Alcohol Depend 2006; 82(Suppl 1): S71-9.
25. Webb MS, Vanable PA, Carey MP, Blair DC. Medication adherence in HIV-infected smokers: the mediating role of depressive symptoms. AIDS Educ Prev 2009; 21: 94-105.